RankingsPricing
  1. US-listed companies
  2. Edwards Lifesciences Corp
  3. Financials
  4. Depreciation & amortization

Edwards Lifesciences CorpEW

Market cap
$49.7B
P/E ratio
SummaryFinancials
Period EndDepreciation & amortization (Million USD)YoY (%)
Dec 31, 2024155+7.11%
Dec 31, 2023145+3.80%
Dec 31, 2022140+3.56%
Dec 31, 2021135+25.75%
Dec 31, 2020107+20.04%
Dec 31, 201989+15.37%
Dec 31, 201877-5.49%
Dec 31, 201782+15.03%
Dec 31, 201671+8.21%
Dec 31, 201566-4.08%
Dec 31, 201469-0.15%
Dec 31, 201369+19.90%
Dec 31, 201257-1.21%
Dec 31, 201158+2.65%
Dec 31, 201057

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)